Moderna Stops mRNA COVID Biologics Plant Construction in Kenya
Moderna, Inc. announced recently that it has suspended its efforts to build a $200–$500 million mRNA (messenger ribonucleic acid) biologics manufacturing facility in Kenya while it determines projected future demand for mRNA biologics in Africa. Company officials concluded that, since the end of the COVID pandemic, interest in COVID-19 biologics in Kenya and Africa has […]
U.S. Shuts Down Risky Novel Animal Virus Research Program
The U.S. government has shut down a research program that searches for new animal viruses in Asia, Africa and Latin America that have the potential to infect humans and cause a pandemic. The $125 million dollar research program called Discovery and Exploration of Emerging Pathogens- Viral Zoonoses (DEEP VZN) focused on the study of novel […]
Mercury Project Funds Research to Convince More People to Get COVID Shots
The Mercury Project, a global consortium of researchers dedicated to “combating the impacts of mis- and disinformation on public health,” is being sponsored by the Social Science Research Council (SSRC) of Brooklyn, New York. SSRC announced on Aug. 23, 2022 that it will provide $7.2 million in grant funding teams doing behavioral research aimed at […]
Kenya Launches Malaria Vaccine Pilot Program
Kenya has become the third African country, along with Ghana and Malawi, to launch a pilot program for the world’s first malaria vaccine, Mosquirix, which has been developed by GlaxoSmithKline (GSK). The vaccine is available to children from six months of age in specific locations in Kenya due to its phased pilot introduction.1 2 Malaria […]
